Boston Scientific Corp. is facing at least three class action lawsuits from shareholders who claim the medical device manufacturer issued misleading statements about the quality of its products, artificially inflating the price of its stock.
http://c.moreover.com/click/here.pl?r400386355
http://c.moreover.com/click/here.pl?r400386355